Compound Vitamin B Premix Nutritional Medicine

Name: Compound Vitamin B Premix Nutritional Medicine
Brand: HEBEI TIANYUAN PHARMACEUTICAL CO., LTD.
SKU: 2102606032

Hebei, ChinaHEBEI TIANYUAN PHARMACEUTICAL CO., LTD.

US$1.00-10.00

1,000 Pieces

Product profile

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Type

The Third Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Content

as Request of Customer

Transport Package

in Plastic Bottles or Bags

Specification

100g, 500g, 1000g, 5kg

Trademark

Origin

China

HS Code

3004909090

Production Capacity

2, 000, 000, 000PCS/Year

Company profile

HEBEI TIANYUAN PHARMACEUTICAL CO., LTD.Hebei, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-07-14 CertifiedNearest Port: Tianjin PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHebei Tianyuan Pharmaceutical Co., Ltd. is a China-based manufacturer specializing in veterinary drugs and related feed products. The supplier reports a 1999 establishment date, more than 10 production lines, eight modern workshops, and GMP-related qualifications and inspections. Its stated product range includes approximately 200 veterinary drugs across injections, powders, tablets, granules, premixes, pour-on solutions, disinfectants, and oral solutions. Reported output includes 400 million oxytetracycline injection pieces and 40 million ivermectin injection pieces annually, while export sales account for 21%–30% of total sales. The company reports exports to Africa, Southeast Asia, the Middle East, and other markets, with stated order lead times of 2–3 months. Evidence supports established manufacturing and international operating capability, but information is insufficient to confirm after-sales systems, customization capability, or broad customer-case depth.

Supplier typeThe supplier is explicitly identified as a manufacturer and describes itself as conducting R&D, production, sales, and technical services for veterinary drugs. Its registered address and operating location are in Shijiazhuang, Hebei, China, and its listed products include veterinary and feed products.

CertificationsThe supplier reports passing GMP inspection audits from Southeast Asia, the Middle East, Africa, and other regions. It also states that it passed GMP dynamic authentication in 2004 and currently operates 10 GMP production lines, although no certificate numbers, validity dates, or issuing authorities are provided.

Production capacityProduction capability is strongly supported by eight modern workshops, 10 GMP production lines, more than 10 reported production lines overall, and stated annual capacities including 1 billion injection ampoules, 80 million powder bags, 10 million disinfectant bottles, and 5,000 metric tons of premix. Reported annual output also includes 400 million oxytetracycline injection pieces and 40 million ivermectin injection pieces.

Client casesThe supplier states that its products are sold to many countries and regions and identifies Africa, Southeast Asia, and the Middle East among its export markets. One trade record links the company to a buyer in Ghana and a dexamethasone injection shipment, but the available evidence is limited and does not establish a broad, independently verified customer portfolio.